FTCD and cancer: Moreover, among this class of targets, there are also some novel candidates whose functions in cancer have not been thoroughly investigated, including three enzymes in the histidine degradation pathway, formimidoyltransferase cyclodeaminase (FTCD), histidase (HAL), and urocanase (UROC).